RECURRENT CANCER
Clinical trials for RECURRENT CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CANCER trials appear
Sign up with your email to follow new studies for RECURRENT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tiny particles supercharge radiation against tough tumors
Disease control TerminatedThis study aimed to test whether injecting special nanoparticles could make proton radiation therapy more effective against recurrent cancers in areas that were previously irradiated. The treatment was intended for adults with specific, hard-to-treat tumors in the head, neck, or …
Matched conditions: RECURRENT CANCER
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Targeted drug trial offers hope for Tough-to-Treat ovarian cancer
Disease control OngoingThis study is testing an experimental drug called CYH33 for women with a specific type of recurrent ovarian cancer (clear cell carcinoma) that has a particular genetic change (PIK3CA mutation). It is for patients whose cancer has come back or persisted after standard chemotherapy…
Matched conditions: RECURRENT CANCER
Phase: PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC